Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.2466 | 0.2817 |
Entamoeba histolytica | hypothetical protein | 0.0084 | 0.337 | 0.432 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.007 | 0.2466 | 0.2933 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0041 | 0.0552 | 0.078 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0187 | 1 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0114 | 0.5249 | 0.72 |
Brugia malayi | phosphoinositide 3'-hydroxykinase p110-alpha subunit, putative | 0.0083 | 0.3311 | 0.4229 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0086 | 0.3468 | 0.4901 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0049 | 0.1117 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0049 | 0.1117 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.004 | 0.0516 | 0.0729 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0187 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0106 | 0.4779 | 0.6753 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0051 | 0.1218 | 0.102 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0049 | 0.1117 | 0.1579 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0114 | 0.5249 | 0.6934 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0049 | 0.1117 | 0.0866 |
Echinococcus multilocularis | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.007 | 0.2466 | 0.1518 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0074 | 0.2705 | 0.3822 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0142 | 0.7076 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0085 | 0.3415 | 0.4826 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0142 | 0.7076 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.2944 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.2952 | 0.4171 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0086 | 0.3468 | 0.4901 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0142 | 0.7076 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0142 | 0.7076 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0142 | 0.7076 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0061 | 0.1835 | 0.1966 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0142 | 0.7076 | 1 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0142 | 0.7076 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0113 | 0.5242 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0096 | 0.4125 | 0.5829 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0142 | 0.7076 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.2944 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0049 | 0.1117 | 0.1579 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0041 | 0.0552 | 0.078 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0113 | 0.5242 | 0.7408 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0104 | 0.4618 | 0.6232 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.2952 | 0.4171 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0142 | 0.7076 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0104 | 0.4618 | 0.6232 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0049 | 0.1117 | 0.0598 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0106 | 0.4779 | 0.6753 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0074 | 0.2705 | 0.3822 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0113 | 0.5242 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0106 | 0.4779 | 0.6753 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0142 | 0.7076 | 0.6709 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0142 | 0.7076 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0113 | 0.5242 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0093 | 0.3931 | 0.5555 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0106 | 0.4779 | 0.6753 |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.0104 | 0.4618 | 0.6526 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0114 | 0.5249 | 0.72 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0049 | 0.1117 | 0.1277 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0082 | 0.0094 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0049 | 0.1117 | 0.0866 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0142 | 0.7076 | 0.6906 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0049 | 0.1117 | 0.0866 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0106 | 0.4779 | 0.6753 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.0104 | 0.4618 | 0.6526 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0084 | 0.337 | 0.432 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0106 | 0.4779 | 0.6753 |
Echinococcus granulosus | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.007 | 0.2466 | 0.1518 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0069 | 0.2351 | 0.2757 |
Giardia lamblia | GTOR | 0.0142 | 0.7076 | 1 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0142 | 0.7076 | 0.6709 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0104 | 0.4618 | 0.6232 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0106 | 0.4779 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.2952 | 0.4171 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0049 | 0.1117 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0122 | 0.5765 | 0.8147 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0106 | 0.4779 | 0.6753 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0142 | 0.7076 | 0.8086 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0113 | 0.5242 | 0.7408 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0041 | 0.0552 | 0.078 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0142 | 0.7076 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0049 | 0.1117 | 0.0866 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.2944 | 0.4161 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0168 | 0.8752 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0086 | 0.3468 | 0.4901 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0142 | 0.7076 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.2952 | 0.4171 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0104 | 0.4618 | 0.6232 |
Entamoeba histolytica | phosphatidylinositol 3-kinase 1, putative | 0.0092 | 0.3859 | 0.5068 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0085 | 0.3415 | 0.4826 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0049 | 0.1117 | 0.0866 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0104 | 0.4618 | 0.6526 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.423 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.421 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.411 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.374 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.314 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.287 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.249 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.224 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.096 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.